臨床検査サービス市場レポート：検査タイプ、サービスプロバイダー、用途、地域別、2024～2032年

世界の臨床検査サービス市場規模は、2023年に2,447億米ドルに達しました。今後、IMARC Groupは、市場は2032年までに3,839億米ドルに達し、2024～2032年の間に5％の成長率（CAGR）を示すと予測しています。糖尿病を管理するための血糖値検査、HbA1c検査、脂質プロファイルなどの診断検査に対する需要の高まり、医療への障壁を低減し、全体的な検査量を増加させることができるため、臨床検査サービスにアクセスするための遠隔医療への依存度の高まり、精密医療の動向の高まりが、市場にプラスの影響を与えています。

臨床検査サービス市場分析：

主要市場促進要因：遺伝子検査、ゲノムシークエンシング、精密医薬のためのバイオマーカー、遺伝子変異、特定の分子標的を同定するための分子診断に対するニーズの高まりが、市場の成長を促進しています。

主要市場動向：遠隔医療（遠隔地でも医療サービスを受けられるようにする）傾向の高まりは、市場展望を良好なものにしています。

地理的動向：北米は、最先端のインフラを備えた高度に発達した医療システムと、医療サービスへの広範なアクセスにより、主導的地位を享受しています。

競合情勢：臨床検査サービス業界の主要市場参入企業には、Abbott Laboratories、Becton, Dickinson and Company、bioMerieux SA、Charles River Laboratories、F. Hoffmann-La Roche Ltd、Illumina Inc.、NeoGenomics Laboratories Inc.、Quest Diagnostics Incorporated、Siemens Healthcare GmbH（Siemens AG）、Thermo Fisher Scientific Inc.があります。

課題と機会：同市場は、規制遵守、高い運営コスト、検査の正確性と信頼性の維持といった課題に直面する一方で、診断技術、個別化医療、遠隔診断サービスといった機会にも遭遇しています。

臨床検査サービス市場傾向

糖尿病有病率の上昇

糖尿病を管理するために、血糖値検査、HbA1c検査、脂質プロファイルなどの診断検査の需要が増加しています。これらの検査は、糖尿病の診断、血糖値のモニタリング、関連する心血管危険因子の評価にも不可欠です。糖尿病を効果的に管理するためには、血糖値を定期的にモニタリングする必要があります。臨床検査室は血糖コントロール、腎機能、脂質レベル、その他のバイオマーカーのモニタリングに役立つため、非常に重要です。糖尿病網膜症、腎症、神経障害などの合併症を予防するために、臨床検査室ではスクリーニング検査を実施しています。これらのスクリーニング検査により、糖尿病の進行予防に役立つタイムリーな介入が可能となります。ポイントオブケア検査（POCT）は、迅速な検査が可能で、すぐに結果が出るため、人々に好まれています。この検査は、糖尿病患者のモニタリングにより効果的です。IDF Diabetes Atlasのウェブサイトに掲載されたデータによると、2045年までに約7億8,300万人が糖尿病に罹患すると予測されています。

精密医療への需要の高まり

IMARC Groupのレポートによると、世界の精密医療市場は2023年に752億米ドルに達しました。バイオマーカー、遺伝子変異、特定の分子標的を特定する精密医療にとって、遺伝子検査、ゲノム配列決定、分子診断が重要です。これらの検査は、疾病リスクの予測、個人の遺伝的特徴に応じた最も効果的な治療法の選択、治療方針の決定に役立つため、臨床検査室で実施されます。コンパニオン診断薬を開発し実施するためには、臨床検査室が非常に重要であり、これが臨床検査サービス市場の成長を強化しています。コンパニオン診断薬は、特定の標的治療の成功率を算出するためのバイオマーカーを同定するために用いられる検査です。これを知ることで、腫瘍学、感染症、その他の治療セグメントにおける治療の選択を最適化することができます。個人における薬剤の反応をモニターするために遺伝的変異を分析することは非常に重要であり、ファーマコゲノミクスはこの分析において重要な役割を果たしています。臨床検査室は、薬剤の有効性、必要量、潜在的な副作用を予測するために、薬理ゲノム検査を提供しています。

遠隔医療の動向の増加

遠隔医療は、遠隔地にいても医師とつながることができるため、現在、人々に好まれています。また、遠隔医療プラットフォームを通じて臨床検査サービスにアクセスすることができ、医療への障壁を減らし、全体的な検査量を増やすことができます。遠隔医療を通じて糖尿病のような慢性疾患を遠隔でモニターすることも容易になります。臨床検査室は、このような疾患の継続的な管理と患者の転帰を改善するために非常に重要です。遠隔医療市場で事業を展開する主要企業は、顧客基盤を拡大するために協業やパートナーシップに注力しています。例えば、2023年、オラクルとZoom Video Communications, Inc.は、より速く、より簡単で、より効果的な遠隔医療サービスを提供するために協業を拡大しました。在宅キットは臨床検査機関から配布され、在宅で採取されたサンプルを処理し、遠隔医療プラットフォームを通じて正確な診断結果を遠隔で提供するもので、臨床検査サービス市場の展望は良好です。

臨床検査サービス市場セグメンテーション：

IMARC Groupは、市場の各セグメントにおける主要動向の分析と、2024～2032年の世界、地域、国レベルの予測を提供しています。当レポートでは、市場を検査タイプ、サービスプロバイダー、アプリケーションに基づいて分類しています。

検査タイプ別内訳

臨床化学が市場シェアの大半を占める

本レポートでは、検査タイプ別に市場を詳細に区分・分析しています。これには、ヒトと腫瘍遺伝学、臨床化学、医療微生物学と細胞学、その他が含まれます。報告書によると、臨床化学が最大のセグメントを占めています。

臨床化学は、血液、尿、その他の体液の生化学的成分を評価する広範な検査と定義できます。様々な医療的疾患を診断し追跡するために、これらの検査はホルモンレベル、臓器機能、電解質バランス、代謝プロセスに関する重要な情報を提供できるため重要です。定期的な健康診断や慢性疾患患者のフォローアップケアにも、多くの臨床化学検査が含まれます。一般的な健康状態を評価し、問題を特定するために、完全代謝パネル（CMP）や基礎代謝パネル（BMP）などの検査が頻繁にオーダーされます。

サービスプロバイダー別の内訳：

病院ベースの検査室が業界で最大のシェアを占める

サービス提供者別の市場の詳細区分と分析も報告書に記載されています。これには、病院ベースの検査室、独立型検査室、クリニックベースの検査室が含まれます。報告書によると、病院ベースの検査室が最大の市場シェアを占めています。

病院ベースの検査室は医療施設に不可欠な要素です。病院内では、外科病棟、外来クリニック、入院患者、救急治療室の患者に診断サービスを提供しています。病院検査室では通常、さまざまな患者層や診療科に対応するため、多種多様な診断検査が可能です。臨床化学、血液学、免疫学、微生物学、分子診断学、病理学サービスなどがこれに含まれます。病院検査室は、様々な診断検査に対するワンストップショップを提供しています。

用途別内訳

バイオ分析とラボ化学サービスが市場の主要セグメントを占める

本レポートでは、市場を用途別に詳細に区分・分析しています。これには、バイオ分析・ラボ化学サービス、毒物検査サービス、細胞・遺伝子治療関連サービス、前臨床・臨床検査関連サービス、創薬・開発関連サービス、その他が含まれます。同レポートによると、バイオ分析・ラボ化学サービスが最大のセグメントを占めています。

臨床診断と生物医療調査は、生物分析とラボ化学サービスによって提供される幅広い検査と分析に大きく依存しています。生体試料中のバイオマーカー、薬剤濃度、代謝物、その他の生化学的成分の測定は、これらのラボが提供するサービスの一つです。薬剤動態学的（PK）と薬力学的（PD）調査は、バイオ分析サービスが製薬とバイオテクノロジー業界に提供する医薬品開発プロセスにおける2つの重要なステップです。臨床検査室は、生物学的マトリックス中の薬剤濃度の測定、臨床検査における薬剤の安全性と有効性の評価、薬剤代謝の評価のための生物分析サービスを提供しています。

地域別内訳

北米が市場をリードし、最大の臨床検査サービス市場シェアを占める

本レポートでは、北米（米国、カナダ）、アジア太平洋（中国、日本、インド、韓国、オーストラリア、インドネシア、その他）、欧州（ドイツ、フランス、英国、イタリア、スペイン、ロシア、その他）、ラテンアメリカ（ブラジル、メキシコ、その他）、中東アフリカを含む主要地域市場についても包括的に分析しています。報告書によると、北米は臨床検査サービスの最大地域市場です。

北米は高度に発達した医療システムを有し、特に米国とカナダでは最先端のインフラと医療サービスへのアクセスが広く普及しています。これには、幅広い臨床検査サービスを提供するクリニック、病院、診断ラボの評判の良いネットワークが含まれます。世界の医療支出に関して言えば、米国は常にトップです。臨床検査サービスの急速な増加は、医療のインフラ、技術、サービスに対する多額の投資に起因しています。疾病モニタリング、オーダーメイド投薬、診断検査といった市場を牽引するイニシアチブは、医療支出によって強化されています。米国で事業を展開する主要企業は、新技術をサポートする検査の提供にも注力しています。例えば、2023年、オランダのバイオテクノロジー企業Detact Diagnostics社は、米国にあるキーン州立大学の研究所で細菌検出サンプリングを開始する計画について発表しました。

競合情勢：

市場調査レポートは、市場の競合情勢についても包括的な分析を提供しています。すべての主要企業の詳細プロファイルも提供しています。臨床検査サービス業界の主要な市場参入企業には、Abbott Laboratories、Becton, Dickinson and Company、bioMerieux SA、Charles River Laboratories、F. Hoffmann-La Roche Ltd、Illumina Inc.、NeoGenomics Laboratories Inc.、Quest Diagnostics Incorporated、Siemens Healthcare GmbH（Siemens AG）、Thermo Fisher Scientific Inc.があります。

（なお、これは主要参入企業の一部一覧であり、完全なリストは報告書に記載されている）。

大手臨床検査サービス企業は、市場での地位を強化し、拡大する診断検査のニーズを満たすために、様々な戦術を積極的に追求しています。企業は、他社との提携や買収によるサービス・ポートフォリオの拡充により、世界中のより多くの患者にリーチし、より幅広い検査の選択肢を提供しています。例えば、2023年、革新的で包括的な検査サービスの世界リーダーであるLabcorpは、マサチューセッツ州を代表する総合学術医療システムであるTufts Medicineと、より大規模な戦略的提携に向けた第一歩として、Tufts Medicineのアウトリーチ検査事業と一部の事業資産を買収することで合意したと発表しました。大手企業はまた、サービスの精度、有効性、納期を向上させるため、自動化、デジタル病理学、次世代シーケンシングなどの最先端技術に多大な投資を行っています。遺伝子診断や分子診断に特化した検査を開発・活用することで、精密医療や集中治療を支えるオーダーメイド医療にも注力しています。

臨床検査サービス市場ニュース：

2023年DiaCarta Ltd.は、米国における体外診断薬（IVD）の規制コンプライアンスと臨床検査室開発検査（LDT）のバリデーションに対するアンメットニーズをサポートするため、ニュージャージー州を拠点とするHopkins MedTech Compliance（HMC）とHopkins MedTech Lab Services（HML）と戦略的パートナーシップを締結したと発表しました。

2023年Aegis Sciences CorporationがHealthTrackRxの毒物学事業部門を買収し、毒物学ポートフォリオを強化。

本レポートで扱う主要質問

• 世界の臨床検査サービス市場はこれまでどのように推移してきたか？
• 世界市場における促進要因、抑制要因、機会は何か？
• それぞれの促進要因、抑制要因、機会が世界市場に与える影響は？
• 主要な地域市場とは？
• 最も魅力的な市場はどの国か？
• 検査タイプ別の市場内訳は？
• 市場で最も魅力的な検査タイプは？
• サービスプロバイダー別の市場内訳は？
• 市場で最も魅力的なサービスプロバイダーは？
• 用途別の市場内訳は？
• 市場で最も魅力的な用途は？
• 市場の競合構造は？
• 世界の臨床検査サービス市場における主要参入企業/企業は？

目次

第1章 序文

第2章 調査範囲と調査手法

• 調査の目的
• ステークホルダー
• データソース
  • 一次情報
  • 二次情報
• 市場推定
  • ボトムアップアプローチ
  • トップダウンアプローチ
• 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

• 概要
• 主要業界動向

第5章 世界の臨床検査サービス市場

• 市場概要
• 市場実績
• COVID-19の影響
• 市場予測

第6章 市場内訳：検査タイプ別

• ヒトと腫瘍の遺伝学
• 臨床化学
• 医療微生物学と細胞学
• その他

第7章 市場内訳：サービスプロバイダー別

• 病院ベースの検査室
• 独立系ラボ
• クリニックベースの検査室

第8章 市場内訳：用途別

• バイオ分析とラボ化学サービス
• 毒性検査サービス
• 細胞・遺伝子治療関連サービス
• 前臨床と臨床検査関連サービス
• 医薬品の発見と開発に関するサービス
• その他

第9章 市場内訳：地域別

• 北米
  • 米国
  • カナダ
• アジア太平洋
  • 中国
  • 日本
  • インド
  • 韓国
  • オーストラリア
  • インドネシア
  • その他
• 欧州
  • ドイツ
  • フランス
  • 英国
  • イタリア
  • スペイン
  • ロシア
  • その他
• ラテンアメリカ
  • ブラジル
  • メキシコ
  • その他
• 中東・アフリカ
  • 市場動向
  • 市場内訳：国別
  • 市場予測

第10章 SWOT分析

• 概要
• 強み
• 弱み
• 機会
• 脅威

第11章 バリューチェーン分析

第12章 ポーターのファイブフォース分析

• 概要
• 買い手の交渉力
• 供給企業の交渉力
• 競合の程度
• 新規参入業者の脅威
• 代替品の脅威

第13章 価格分析

第14章 競合情勢

• 市場構造
• 主要企業
• 主要企業のプロファイル
  • Abbott Laboratories
  • Becton, Dickinson and Company
  • bioMerieux SA
  • Charles River Laboratories
  • F. Hoffmann-La Roche Ltd
  • Illumina Inc.
  • NeoGenomics Laboratories Inc.
  • Quest Diagnostics Incorporated
  • Siemens Healthcare GmbH（Siemens AG）
  • Thermo Fisher Scientific Inc.

List of Figures

• Figure 1: Global: Clinical Laboratory Services Market: Major Drivers and Challenges
• Figure 2: Global: Clinical Laboratory Services Market: Sales Value (in Billion US$), 2018-2023
• Figure 3: Global: Clinical Laboratory Services Market Forecast: Sales Value (in Billion US$), 2024-2032
• Figure 4: Global: Clinical Laboratory Services Market: Breakup by Test Type (in %), 2023
• Figure 5: Global: Clinical Laboratory Services Market: Breakup by Service Provider (in %), 2023
• Figure 6: Global: Clinical Laboratory Services Market: Breakup by Application (in %), 2023
• Figure 7: Global: Clinical Laboratory Services Market: Breakup by Region (in %), 2023
• Figure 8: Global: Clinical Laboratory Services (Human and Tumor Genetics) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 9: Global: Clinical Laboratory Services (Human and Tumor Genetics) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 10: Global: Clinical Laboratory Services (Clinical Chemistry) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 11: Global: Clinical Laboratory Services (Clinical Chemistry) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 12: Global: Clinical Laboratory Services (Medical Microbiology and Cytology) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 13: Global: Clinical Laboratory Services (Medical Microbiology and Cytology) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 14: Global: Clinical Laboratory Services (Other Test Types) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 15: Global: Clinical Laboratory Services (Other Test Types) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 16: Global: Clinical Laboratory Services (Hospital-Based Laboratories) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 17: Global: Clinical Laboratory Services (Hospital-Based Laboratories) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 18: Global: Clinical Laboratory Services (Stand-Alone Laboratories) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 19: Global: Clinical Laboratory Services (Stand-Alone Laboratories) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 20: Global: Clinical Laboratory Services (Clinic-Based Laboratories) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 21: Global: Clinical Laboratory Services (Clinic-Based Laboratories) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 22: Global: Clinical Laboratory Services (Bioanalytical and Lab Chemistry Services) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 23: Global: Clinical Laboratory Services (Bioanalytical and Lab Chemistry Services) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 24: Global: Clinical Laboratory Services (Toxicology Testing Services) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 25: Global: Clinical Laboratory Services (Toxicology Testing Services) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 26: Global: Clinical Laboratory Services (Cell and Gene Therapy Related Services) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 27: Global: Clinical Laboratory Services (Cell and Gene Therapy Related Services) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 28: Global: Clinical Laboratory Services (Preclinical and Clinical Trial Related Services) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 29: Global: Clinical Laboratory Services (Preclinical and Clinical Trial Related Services) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 30: Global: Clinical Laboratory Services (Drug Discovery and Development Related Services) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 31: Global: Clinical Laboratory Services (Drug Discovery and Development Related Services) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 32: Global: Clinical Laboratory Services (Other Applications) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 33: Global: Clinical Laboratory Services (Other Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 34: North America: Clinical Laboratory Services Market: Sales Value (in Million US$), 2018 & 2023
• Figure 35: North America: Clinical Laboratory Services Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 36: United States: Clinical Laboratory Services Market: Sales Value (in Million US$), 2018 & 2023
• Figure 37: United States: Clinical Laboratory Services Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 38: Canada: Clinical Laboratory Services Market: Sales Value (in Million US$), 2018 & 2023
• Figure 39: Canada: Clinical Laboratory Services Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 40: Asia-Pacific: Clinical Laboratory Services Market: Sales Value (in Million US$), 2018 & 2023
• Figure 41: Asia-Pacific: Clinical Laboratory Services Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 42: China: Clinical Laboratory Services Market: Sales Value (in Million US$), 2018 & 2023
• Figure 43: China: Clinical Laboratory Services Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 44: Japan: Clinical Laboratory Services Market: Sales Value (in Million US$), 2018 & 2023
• Figure 45: Japan: Clinical Laboratory Services Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 46: India: Clinical Laboratory Services Market: Sales Value (in Million US$), 2018 & 2023
• Figure 47: India: Clinical Laboratory Services Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 48: South Korea: Clinical Laboratory Services Market: Sales Value (in Million US$), 2018 & 2023
• Figure 49: South Korea: Clinical Laboratory Services Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 50: Australia: Clinical Laboratory Services Market: Sales Value (in Million US$), 2018 & 2023
• Figure 51: Australia: Clinical Laboratory Services Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 52: Indonesia: Clinical Laboratory Services Market: Sales Value (in Million US$), 2018 & 2023
• Figure 53: Indonesia: Clinical Laboratory Services Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 54: Others: Clinical Laboratory Services Market: Sales Value (in Million US$), 2018 & 2023
• Figure 55: Others: Clinical Laboratory Services Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 56: Europe: Clinical Laboratory Services Market: Sales Value (in Million US$), 2018 & 2023
• Figure 57: Europe: Clinical Laboratory Services Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 58: Germany: Clinical Laboratory Services Market: Sales Value (in Million US$), 2018 & 2023
• Figure 59: Germany: Clinical Laboratory Services Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 60: France: Clinical Laboratory Services Market: Sales Value (in Million US$), 2018 & 2023
• Figure 61: France: Clinical Laboratory Services Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 62: United Kingdom: Clinical Laboratory Services Market: Sales Value (in Million US$), 2018 & 2023
• Figure 63: United Kingdom: Clinical Laboratory Services Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 64: Italy: Clinical Laboratory Services Market: Sales Value (in Million US$), 2018 & 2023
• Figure 65: Italy: Clinical Laboratory Services Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 66: Spain: Clinical Laboratory Services Market: Sales Value (in Million US$), 2018 & 2023
• Figure 67: Spain: Clinical Laboratory Services Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 68: Russia: Clinical Laboratory Services Market: Sales Value (in Million US$), 2018 & 2023
• Figure 69: Russia: Clinical Laboratory Services Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 70: Others: Clinical Laboratory Services Market: Sales Value (in Million US$), 2018 & 2023
• Figure 71: Others: Clinical Laboratory Services Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 72: Latin America: Clinical Laboratory Services Market: Sales Value (in Million US$), 2018 & 2023
• Figure 73: Latin America: Clinical Laboratory Services Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 74: Brazil: Clinical Laboratory Services Market: Sales Value (in Million US$), 2018 & 2023
• Figure 75: Brazil: Clinical Laboratory Services Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 76: Mexico: Clinical Laboratory Services Market: Sales Value (in Million US$), 2018 & 2023
• Figure 77: Mexico: Clinical Laboratory Services Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 78: Others: Clinical Laboratory Services Market: Sales Value (in Million US$), 2018 & 2023
• Figure 79: Others: Clinical Laboratory Services Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 80: Middle East and Africa: Clinical Laboratory Services Market: Sales Value (in Million US$), 2018 & 2023
• Figure 81: Middle East and Africa: Clinical Laboratory Services Market: Breakup by Country (in %), 2023
• Figure 82: Middle East and Africa: Clinical Laboratory Services Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 83: Global: Clinical Laboratory Services Industry: SWOT Analysis
• Figure 84: Global: Clinical Laboratory Services Industry: Value Chain Analysis
• Figure 85: Global: Clinical Laboratory Services Industry: Porter's Five Forces Analysis

List of Tables

• Table 1: Global: Clinical Laboratory Services Market: Key Industry Highlights, 2023 and 2032
• Table 2: Global: Clinical Laboratory Services Market Forecast: Breakup by Test Type (in Million US$), 2024-2032
• Table 3: Global: Clinical Laboratory Services Market Forecast: Breakup by Service Provider (in Million US$), 2024-2032
• Table 4: Global: Clinical Laboratory Services Market Forecast: Breakup by Application (in Million US$), 2024-2032
• Table 5: Global: Clinical Laboratory Services Market Forecast: Breakup by Region (in Million US$), 2024-2032
• Table 6: Global: Clinical Laboratory Services Market: Competitive Structure
• Table 7: Global: Clinical Laboratory Services Market: Key Players

The global clinical laboratory services market size reached US$ 244.7 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 383.9 Billion by 2032, exhibiting a growth rate (CAGR) of 5% during 2024-2032. The growing demand for diagnostic tests, such as blood glucose tests, HbA1c testing, and lipid profiles to manage diabetes, rising reliance on telehealth to access clinical laboratory services as it can reduce barriers to healthcare and increase overall testing volumes, and increasing trend of precision medicines are positively influencing the market.

Clinical Laboratory Services Market Analysis:

Major Market Drivers: The rising need for genetic testing, genomic sequencing, and molecular diagnostics to identify biomarkers, genetic variations, and specific molecular targets for precision medicines is propelling the market growth.

Key Market Trends: The growing trend of telehealth, which enable people to access healthcare services even at remote locations is offering a favorable market outlook.

Geographical Trends: North America is enjoying the leading position on account of its highly developed healthcare systems with cutting-edge infrastructure and widespread access to healthcare services.

Competitive Landscape: Some of the major market players in the clinical laboratory services industry include Abbott Laboratories, Becton, Dickinson and Company, bioMerieux SA, Charles River Laboratories, F. Hoffmann-La Roche Ltd, Illumina Inc., NeoGenomics Laboratories Inc., Quest Diagnostics Incorporated, Siemens Healthcare GmbH (Siemens AG), Thermo Fisher Scientific Inc., among many others.

Challenges and Opportunities: While the market faces challenges, such as regulatory compliance, high operational costs, and maintaining accuracy and reliability of tests, it also encounters opportunities in diagnostic technologies, personalized medicine, and remote diagnostic services.

Clinical Laboratory Services Market Trends:

Rising prevalence of diabetes

There is a rise in the demand for diagnostic tests, such as blood glucose tests, HbA1c testing, and lipid profiles, to manage diabetes. These tests are also crucial for diagnosing diabetes, monitoring blood sugar levels, and assessing associated cardiovascular risk factors. To effectively manage diabetes, there is a need of monitoring blood glucose levels regularly. Clinical laboratories are very essential as they can help in monitoring glycemic control, kidney function, lipid levels, and other biomarkers. For preventing complications, such as diabetic retinopathy, nephropathy, and neuropathy, clinical laboratories perform screening tests. These screening tests allow for timely intervention that can assist in preventing progression of diabetes. People are preferring point-of-care testing (POCT) as it allows rapid testing and immediate results. This testing is more successful for monitoring patients with diabetes. As per the data published on the website of IDF Diabetes Atlas, it is projected that around 783 million people will be suffering from diabetes by 2045.

Growing demand for precision medicine

The IMARC Group's report shows that the global precision medicine market reached US$ 75.2 Billion in 2023. Genetic testing, genomic sequencing, and molecular diagnostics are important for precision medicines to identify biomarkers, genetic variations, and specific molecular targets. These tests are performed in clinical laboratories, as they help in predicting disease risks, selecting most effective therapies as individual's genetic characteristics, and guiding treatment decisions. To develop and perform companion diagnostics, clinical laboratories are very crucial, which is strengthening the clinical laboratory services market growth. Companion diagnostics are tests used to identify biomarkers to calculate the success rate of any specific targeted therapy. After knowing this, treatment choices in oncology, infectious diseases, and other therapeutic areas can be optimized. It is very important to analyze genetic variations to monitor the respond of medications in individuals, and pharmacogenomic plays an important role in this analysis. Clinical laboratories provide pharmacogenomic testing to predict drug efficacy, dosage requirements, and potential adverse reactions.

Increasing trend of telehealth

People are preferring telehealth nowadays, as it can help connect with doctors even if they are at remote locations. They can also access clinical laboratory services through telehealth platforms, reducing barriers to healthcare and increasing overall testing volumes. It becomes easy to monitor chronic conditions like diabetes remotely through telehealth. Clinical laboratories are very important for the ongoing management of this diseases and improving patient outcomes. Key players operating in the telehealth market are focusing on collaborations and partnerships to expand their customer base. For instance, in 2023, Oracle and Zoom Video Communications, Inc. expanded their collaboration to deliver faster, easier, and more effective telehealth services. Home-based kits are distributed by clinical laboratories and then they process the samples collected at home to provide accurate diagnostic results remotely through telehealth platforms, thereby offering a favorable clinical laboratory services market outlook.

Clinical Laboratory Services Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the global, regional, and country levels for 2024-2032. Our report has categorized the market based on test type, service provider, and application.

Breakup by Test Type:

Human and Tumor Genetics

Clinical Chemistry

Medical Microbiology and Cytology

Others

Clinical chemistry accounts for the majority of the market share

The report has provided a detailed breakup and analysis of the market based on the test type. This includes human and tumor genetics, clinical chemistry, medical microbiology and cytology, and others. According to the report, clinical chemistry represents the largest segment.

Clinical chemistry can be defined as a broad range of tests that assess the biochemical components of blood, urine, and other bodily fluids. To diagnose and track a variety of medical disorders, these tests are important as they can provide vital information on hormone levels, organ function, electrolyte balance, and metabolic processes. Regular health screenings and follow-up care for patients with chronic diseases also include a large number of clinical chemistry tests. To evaluate general health status and identify problems, tests such as complete metabolic panels (CMP) and basic metabolic panels (BMP) are frequently ordered.

Breakup by Service Provider:

Hospital-Based Laboratories

Stand-Alone Laboratories

Clinic-Based Laboratories

Hospital-based laboratories hold the largest share of the industry

A detailed breakup and analysis of the market based on the service provider have also been provided in the report. This includes hospital-based laboratories, stand-alone laboratories, and clinic-based laboratories. According to the report, hospital-based laboratories account for the largest market share.

Hospital-based laboratories are essential components of healthcare facilities because they are closely linked to the whole range of patient services. Within the hospital setting, they provide diagnostic services for surgical units, outpatient clinics, inpatients, and patients in the emergency room. A wide variety of diagnostic tests are usually available at hospital laboratories to support different patient demographics and medical specialties. Clinical chemistry, hematology, immunology, microbiology, molecular diagnostics, and pathology services are all included in this. They offer a one-stop shop for a variety of diagnostic testing requirements.

Breakup by Application:

Bioanalytical and Lab Chemistry Services

Toxicology Testing Services

Cell and Gene Therapy Related Services

Preclinical and Clinical Trial Related Services

Drug Discovery and Development Related Services

Others

Bioanalytical and lab chemistry services represent the leading market segment

The report has provided a detailed breakup and analysis of the market based on the application. This includes bioanalytical and lab chemistry services, toxicology testing services, cell and gene therapy related services, preclinical and clinical trial related services, drug discovery and development related services, and others. According to the report, bioanalytical and lab chemistry services represent the largest segment.

Clinical diagnostics and biomedical research depend heavily on a wide range of tests and analyses that are provided by bioanalytical and lab chemistry services. Assays for biomarkers, drug concentrations, metabolites, and other biochemical components in biological samples are among the services provided by these labs. Pharmacokinetic (PK) and pharmacodynamic (PD) investigations are two important steps in the drug development process that bioanalytical services provide for the pharmaceutical and biotechnology industries. Clinical laboratories offer bioanalytical services for measuring drug concentrations in biological matrices, evaluating medication safety and efficacy in clinical trials, and assessing drug metabolism.

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

North America leads the market, accounting for the largest clinical laboratory services market share

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America represents the largest regional market for clinical laboratory services.

North America has highly developed healthcare systems with cutting-edge infrastructure and widespread access to healthcare services, especially in the United States and Canada. This includes a reputable network of clinics, hospitals, and diagnostic labs that provide a wide range of clinical laboratory services. When it comes to healthcare spending worldwide, the US regularly comes in top. The rapid rise of clinical laboratory services can be attributed to the significant investments made in healthcare infrastructure, technology, and services. The market-driving initiatives of illness monitoring, tailored medication, and diagnostic testing are bolstered by healthcare spending. Key players operating in US also focusing on providing tests that support novel technology. For instance, in 2023, Dutch biotech firm Detact Diagnostics' announced about its plans to begin bacterial detection sampling at its laboratory in the Keene State College situated in the US.

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the major market players in the clinical laboratory services industry include Abbott Laboratories, Becton, Dickinson and Company, bioMerieux SA, Charles River Laboratories, F. Hoffmann-La Roche Ltd, Illumina Inc., NeoGenomics Laboratories Inc., Quest Diagnostics Incorporated, Siemens Healthcare GmbH (Siemens AG), and Thermo Fisher Scientific Inc.

(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)

Leading clinical laboratory services companies are aggressively pursuing a range of tactics to fortify their positions in the market and satisfy the expanding need for diagnostic tests. Businesses are reaching more patients worldwide and providing a wider choice of tests by partnering with other companies and increasing their service portfolios through acquisitions. For instance, in 2023, Labcorp, a global leader of innovative and comprehensive laboratory services, announced an agreement with Tufts Medicine, a leading integrated academic health system in Massachusetts, to acquire the Tufts Medicine outreach laboratory business and select operating assets as a first step towards a larger strategic partnership. Major firms are also making significant investments in cutting-edge technologies including automation, digital pathology, and next-generation sequencing to increase the precision, effectiveness, and turnaround times of their services. By creating and utilizing specific tests for genetic and molecular diagnostics, they are also concentrating on customized medicine, which supports precision medicine and focused therapeutics.

Clinical Laboratory Services Market News:

In 2023: DiaCarta Ltd. announced that the company has formed strategic partnership with New Jersey-based Hopkins MedTech Compliance (HMC) and Hopkins MedTech Lab Services (HML) to support the unmet needs for regulatory compliance and laboratory developed test (LDT) validation of in vitro diagnostics (IVD) in the United States.

In 2023: Aegis Sciences Corporation acquired HealthTrackRx's Toxicology business unit to enhance its toxicology portfolio.

Key Questions Answered in This Report:

• How has the global clinical laboratory services market performed so far, and how will it perform in the coming years?
• What are the drivers, restraints, and opportunities in the global market?
• What is the impact of each driver, restraint, and opportunity on the global market?
• What are the key regional markets?
• Which countries represent the most attractive market?
• What is the breakup of the market based on the test type?
• Which is the most attractive test type in the market?
• What is the breakup of the market based on the service provider?
• Which is the most attractive service provider in the market?
• What is the breakup of the market based on the application?
• Which is the most attractive application in the market?
• What is the competitive structure of the market?
• Who are the key players/companies in the global clinical laboratory services market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Clinical Laboratory Services Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Forecast

6 Market Breakup by Test Type

• 6.1 Human and Tumor Genetics
  • 6.1.1 Market Trends
  • 6.1.2 Market Forecast
• 6.2 Clinical Chemistry
  • 6.2.1 Market Trends
  • 6.2.2 Market Forecast
• 6.3 Medical Microbiology and Cytology
  • 6.3.1 Market Trends
  • 6.3.2 Market Forecast
• 6.4 Others
  • 6.4.1 Market Trends
  • 6.4.2 Market Forecast

7 Market Breakup by Service Provider

• 7.1 Hospital-Based Laboratories
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 Stand-Alone Laboratories
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast
• 7.3 Clinic-Based Laboratories
  • 7.3.1 Market Trends
  • 7.3.2 Market Forecast

8 Market Breakup by Application

• 8.1 Bioanalytical and Lab Chemistry Services
  • 8.1.1 Market Trends
  • 8.1.2 Market Forecast
• 8.2 Toxicology Testing Services
  • 8.2.1 Market Trends
  • 8.2.2 Market Forecast
• 8.3 Cell and Gene Therapy Related Services
  • 8.3.1 Market Trends
  • 8.3.2 Market Forecast
• 8.4 Preclinical and Clinical Trial Related Services
  • 8.4.1 Market Trends
  • 8.4.2 Market Forecast
• 8.5 Drug Discovery and Development Related Services
  • 8.5.1 Market Trends
  • 8.5.2 Market Forecast
• 8.6 Others
  • 8.6.1 Market Trends
  • 8.6.2 Market Forecast

9 Market Breakup by Region

• 9.1 North America
  • 9.1.1 United States
    • 9.1.1.1 Market Trends
    • 9.1.1.2 Market Forecast
  • 9.1.2 Canada
    • 9.1.2.1 Market Trends
    • 9.1.2.2 Market Forecast
• 9.2 Asia-Pacific
  • 9.2.1 China
    • 9.2.1.1 Market Trends
    • 9.2.1.2 Market Forecast
  • 9.2.2 Japan
    • 9.2.2.1 Market Trends
    • 9.2.2.2 Market Forecast
  • 9.2.3 India
    • 9.2.3.1 Market Trends
    • 9.2.3.2 Market Forecast
  • 9.2.4 South Korea
    • 9.2.4.1 Market Trends
    • 9.2.4.2 Market Forecast
  • 9.2.5 Australia
    • 9.2.5.1 Market Trends
    • 9.2.5.2 Market Forecast
  • 9.2.6 Indonesia
    • 9.2.6.1 Market Trends
    • 9.2.6.2 Market Forecast
  • 9.2.7 Others
    • 9.2.7.1 Market Trends
    • 9.2.7.2 Market Forecast
• 9.3 Europe
  • 9.3.1 Germany
    • 9.3.1.1 Market Trends
    • 9.3.1.2 Market Forecast
  • 9.3.2 France
    • 9.3.2.1 Market Trends
    • 9.3.2.2 Market Forecast
  • 9.3.3 United Kingdom
    • 9.3.3.1 Market Trends
    • 9.3.3.2 Market Forecast
  • 9.3.4 Italy
    • 9.3.4.1 Market Trends
    • 9.3.4.2 Market Forecast
  • 9.3.5 Spain
    • 9.3.5.1 Market Trends
    • 9.3.5.2 Market Forecast
  • 9.3.6 Russia
    • 9.3.6.1 Market Trends
    • 9.3.6.2 Market Forecast
  • 9.3.7 Others
    • 9.3.7.1 Market Trends
    • 9.3.7.2 Market Forecast
• 9.4 Latin America
  • 9.4.1 Brazil
    • 9.4.1.1 Market Trends
    • 9.4.1.2 Market Forecast
  • 9.4.2 Mexico
    • 9.4.2.1 Market Trends
    • 9.4.2.2 Market Forecast
  • 9.4.3 Others
    • 9.4.3.1 Market Trends
    • 9.4.3.2 Market Forecast
• 9.5 Middle East and Africa
  • 9.5.1 Market Trends
  • 9.5.2 Market Breakup by Country
  • 9.5.3 Market Forecast

10 SWOT Analysis

• 10.1 Overview
• 10.2 Strengths
• 10.3 Weaknesses
• 10.4 Opportunities
• 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

• 12.1 Overview
• 12.2 Bargaining Power of Buyers
• 12.3 Bargaining Power of Suppliers
• 12.4 Degree of Competition
• 12.5 Threat of New Entrants
• 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

• 14.1 Market Structure
• 14.2 Key Players
• 14.3 Profiles of Key Players
  • 14.3.1 Abbott Laboratories
    • 14.3.1.1 Company Overview
    • 14.3.1.2 Product Portfolio
    • 14.3.1.3 Financials
    • 14.3.1.4 SWOT Analysis
  • 14.3.2 Becton, Dickinson and Company
    • 14.3.2.1 Company Overview
    • 14.3.2.2 Product Portfolio
    • 14.3.2.3 Financials
    • 14.3.2.4 SWOT Analysis
  • 14.3.3 bioMerieux SA
    • 14.3.3.1 Company Overview
    • 14.3.3.2 Product Portfolio
    • 14.3.3.3 Financials
    • 14.3.3.4 SWOT Analysis
  • 14.3.4 Charles River Laboratories
    • 14.3.4.1 Company Overview
    • 14.3.4.2 Product Portfolio
    • 14.3.4.3 Financials
    • 14.3.4.4 SWOT Analysis
  • 14.3.5 F. Hoffmann-La Roche Ltd
    • 14.3.5.1 Company Overview
    • 14.3.5.2 Product Portfolio
    • 14.3.5.3 SWOT Analysis
  • 14.3.6 Illumina Inc.
    • 14.3.6.1 Company Overview
    • 14.3.6.2 Product Portfolio
    • 14.3.6.3 Financials
    • 14.3.6.4 SWOT Analysis
  • 14.3.7 NeoGenomics Laboratories Inc.
    • 14.3.7.1 Company Overview
    • 14.3.7.2 Product Portfolio
    • 14.3.7.3 Financials
  • 14.3.8 Quest Diagnostics Incorporated
    • 14.3.8.1 Company Overview
    • 14.3.8.2 Product Portfolio
    • 14.3.8.3 Financials
    • 14.3.8.4 SWOT Analysis
  • 14.3.9 Siemens Healthcare GmbH (Siemens AG)
    • 14.3.9.1 Company Overview
    • 14.3.9.2 Product Portfolio
  • 14.3.10 Thermo Fisher Scientific Inc.
    • 14.3.10.1 Company Overview
    • 14.3.10.2 Product Portfolio
    • 14.3.10.3 Financials
    • 14.3.10.4 SWOT Analysis